TN2011000066A1 - DIOXA-BICYCLO DERIVATIVES [3.2.1] OCTANE -2,3,4-TRIOL - Google Patents

DIOXA-BICYCLO DERIVATIVES [3.2.1] OCTANE -2,3,4-TRIOL

Info

Publication number
TN2011000066A1
TN2011000066A1 TN2011000066A TN2011000066A TN2011000066A1 TN 2011000066 A1 TN2011000066 A1 TN 2011000066A1 TN 2011000066 A TN2011000066 A TN 2011000066A TN 2011000066 A TN2011000066 A TN 2011000066A TN 2011000066 A1 TN2011000066 A1 TN 2011000066A1
Authority
TN
Tunisia
Prior art keywords
dioxa
triol
octane
disorders
treatment
Prior art date
Application number
TN2011000066A
Other languages
French (fr)
Inventor
Benjamin Micah Collman
Vincent Mascitti
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IB2009/053626 external-priority patent/WO2010023594A1/en
Application filed by Pfizer filed Critical Pfizer
Publication of TN2011000066A1 publication Critical patent/TN2011000066A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

IL EST DECRIT DANS LE PRESENT MEMOIRE DES COMPOSES DE FORMULE(I) ET LEURS UTILISATIONS POUR LE TRAITEMENT DE MALADIES, D' AFFECTIONS ET DE TROUBLES A MEDIATION PAR DES INHIBITEURS DU TRANSPORTEUR SODUIM - GLUCOSE (EN PARTICULIER DES INHIBITEURS DE SGLT2) . LES COMPOSES DECRITS DANS LE PRESENT MEMOIRE SONT UTILES POUR LA PREVENTION ET LE TRAITEMENT DE L' OBESITE ET DE SES COMORBIDITES ASSOCIEES , EN PARTICULIER LE DIABETE DE TYPE II (TYPE2) .IT IS DESCRIBED IN THE PRESENT MEMORY OF THE COMPOUNDS OF FORMULA (I) AND THEIR USES FOR THE TREATMENT OF DISEASES, DISORDERS AND MEDIATION DISORDERS BY INHIBITORS OF THE SODUIM - GLUCOSE CARRIER (ESPECIALLY SGLT2 INHIBITORS). THE COMPOUNDS DESCRIBED IN THIS MEMORY ARE USEFUL FOR THE PREVENTION AND TREATMENT OF OBESITY AND ITS ASSOCIATED COMORBIDITIES, ESPECIALLY DIABETES TYPE II (TYPE2).

TN2011000066A 2009-08-17 2011-02-10 DIOXA-BICYCLO DERIVATIVES [3.2.1] OCTANE -2,3,4-TRIOL TN2011000066A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2009/053626 WO2010023594A1 (en) 2008-08-28 2009-08-17 Dioxa-bicyclo[3.2.1.]octane-2,3,4-triol derivatives

Publications (1)

Publication Number Publication Date
TN2011000066A1 true TN2011000066A1 (en) 2012-09-05

Family

ID=55024379

Family Applications (1)

Application Number Title Priority Date Filing Date
TN2011000066A TN2011000066A1 (en) 2009-08-17 2011-02-10 DIOXA-BICYCLO DERIVATIVES [3.2.1] OCTANE -2,3,4-TRIOL

Country Status (1)

Country Link
TN (1) TN2011000066A1 (en)

Similar Documents

Publication Publication Date Title
EA201100266A1 (en) DIOXA-BICYCLO [3.2.1] OKTAN-2,3,4-TRIOL DERIVATIVES
MA33044B1 (en) PHARMACEUTICAL COMPOSITION CONTAINING GLUCOPYRANOSYL DIPHENYLMETHANE DERIVATIVES, ITS GALENIC DOSAGE FORM, PREPARATION METHOD AND USES FOR ENHANCED GLYCEMIC REGULATION IN PATIENT
TW200609227A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
MA33734B1 (en) N1-PYRAZOLOSPIROCETONE ACETYL-COA CARBOXYLASE INHIBITORS
MA31158B1 (en) Tricyclic compounds and their use as modifiers for glucocorticoid receptors.
MA33046B1 (en) Pharmaceutical composition containing sglt-2 inhibitor and dpp-iv inhibitor and optionally another agent against diabetes and its use
EA201290267A1 (en) DERIVATIVES OF DIOXABICICLO [3.2.1] OKTAN-2,3,4-TRIOL
MA33155B1 (en) ORGANIC COMPOUNDS AND USES THEREOF
MA28436B1 (en) SELECTIVE MODULATORS OF THE ESTROGEN RECEPTOR FOR THE TREATMENT OF VASOMOTE SYMPTOMS
EA200801826A1 (en) DEUTERATED CATECHOLAMINE DERIVATIVES AND MEDICINES CONTAINING INDICATED COMPOUNDS
MY156822A (en) Indole derivatives as s1p1 receptor agonists
EA200700909A1 (en) AZAINDOLKARBOXAMIDES
BRPI0511874A (en) pyrrolopyridine derivatives
CY1111128T1 (en) 17-PHOSPHORUS STEROID PRODUCER USEFUL AS PROCESSOR RECEPTOR MODIFIERS
TW200621732A (en) Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals
MA33753B1 (en) New Ariel Mycophenolate, methods of preparation and uses
PT1745010E (en) Substituted cyclohexyl-1,4-diamine derivatives
NO20081681L (en) N- [1,3,4] -thiadiazol-2-yl-benzenesulfonamides, process for their preparation and their use as pharmaceuticals
MA30665B1 (en) TREATMENT OF RHEUMATOID DISEASES WITH DELAYED RELEASE GLUCOCORTICOIDS.
TN2011000066A1 (en) DIOXA-BICYCLO DERIVATIVES [3.2.1] OCTANE -2,3,4-TRIOL
IL191670A0 (en) Compounds for the inhibition of apoptosis
TW200734335A (en) Compounds
ATE410415T1 (en) NEW CONNECTIONS
BRPI0419229A (en) thiophenopyrimidinone derivatives substituted as 17betahydroxysteroid dehydrogenase inhibitors, use and pharmaceutical composition
UA54251U (en) Method of biological prevention of lead intoxication